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Important Aspects of the Evidence for
TCDD Carcinogenicity in Man
by Eric S. Johnson'
Most oftheevidence forthecarcinogenicity of2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)inhumanshascenteredon
whetherTCDDcausessoft-tissuesarcomas(SIS)andmal lymphomas (ML).Recently, reportsfrom twoofthelargest
occupational cohortstudieshavebecomeavailable. Acritical reappraisaloftheseandotherrecentreportsindicatesthat
it isunlikely that TCDDcauses malignantlymphomas inhumans. ForSIS, theevidenceforanetiologicroleforTCDD
is not convincing. However, more data andfurtherclarification are needed before aclearandobjectiveevaluation can
be made. Factors such as level ofexposure, sex, and hostsusceptibility may becritical determinants ofwhether cancer
occurs; thereisevidence from both humansandanimalsthatthesefactors play arole, andthereforethesefactorsshould
beconsideredinfutureevaluations. Thereisaseriousneedtoruleoutthepossibility thatobservedeffectsareduetoother
concomitantexposures. ConsiderationofthecarcinogeniceffectsofTCDDinaninalsrevealsconsistencywiththehuman
dataand pointstoothercancerssuchasthoseofthethyroidglandandlung, forexample, whicharemorelikely candidates
forinvestigatingtheroleofTCDDintheiroccurrence, whileatthesametimeprovidingabasisforabetterunderstand-
ingand interpretation ofthehumandata. Therearenowsufficientepidemiologicstudiesinplacethatwill provideabetter
climate for a definitive evaluation in the nearfuture.
Introduction
The issue of2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and
possible cancer effects in humans has very important implica-
tions forthe research on mechanisms ofaction, andbiologic ef-
fectsofchemicals ingeneral, acrossdifferentspecies, aswell as
implications for how policy makers assess public risk from
chemicals inthe future. Whether or notTCDD isfound to be a
human carcinogen, the experience gained from the study of
TCDD will have a profound effect on how scientists, policy
makers, andthe public react in the future topossible long-term
healtheffectsoftoxic chemicals intheenvironment. Itisimpor-
tant, therefore, that everypieceofevidencebecriticallyevaluated
for an objective assessment ofthe carcinogenicity ofTCDD in
humans. IfTCDD iscarcinogenic inhumans, itis importantthat
the site(s) that are targets for itsactionbecorrectlyidentified. A
recenteditorial (1) has precipitated theneed forfurther clarifica-
tion and reappraisal oftheliterature. Thepresent paperdiscusses
certain issues ofimportance and examines in great detail those
studies that have reported a statistically significant association
between TCDD exposure and cancer.
Thediscussion ofTCDDcarcinogenicity inhumans so farhas
centered primarily around whether or not it causes soft-tissue
sarcomas (STS) and malignant lymphomas (ML), mainly
because these were the first sites an association was suspected
from case reportsandcase-control studies, andhencethese were
the sites mostfrequently studied. However, areviewofatotalof
17 case-control studies (2) that have investigated this putative
association shows that only 6 have reported a statistically sig-
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nificantassociationbetweenSTS, ML, andexposuretophenoxy-
acetic acids and chlorophenols likely to be contaminated with
TCDD in the study group as a whole or in any subgroup of it
(3-8). Thesesix studiesthereforedeserveclosescrutinybecause
oftheir uniqueness. Fiveofthe six positive studies (3-7) were
conducted in Sweden by the same two principal investigators,
HardellandEriksson, andthesixth studywasconducted inIta-
ly by Vineis and colleagues (8).
Hardell and Eriksson Case-Control
Studies
Thereisevidenceofpossible interviewerbiasandrecall bias
inthe Hardell and Eriksson studies (3-7). Inthe Hardell series,
the risks ofSTS and ML for exposure to phenoxy compounds
were2.6and3.0, respectively, usingquestionnairedataonly (9).
Theserisks increasedto5.3 (i.e., doubled) and4.8forSTSand
ML, respectively, whenquestionnairedataweresupplemented
by interview data, which was the formal analysis used by the
authors (3,6). A similar picture was also seen in the Eriksson
studies (4,9). Thus, use oftelephone interview toverify a) all
doubtful questionnaire responses in relation toexposure andb)
all exposures reported in the questionnaire by a subset of the
study groupofagricultureandforestry workersonly, resulted in
disproportionately morecontrolsbeingreclassifiedasunexposed
thancases. Atrulyunbiasedverificationofexposure wouldhave
resulted in similar proportions reclassified in both cases and
controls.
Similarly, in one ofthe more recent studies (7), the relative
risk obtained for exposure to phenoxy acids was 3.3 using
population controls, but was only 2.2 using cancer controls,E. S. JOHNSON
prompting theauthors toentertain thepossibilityofrecallbias,
in spiteofthefactthat aprevious coloncancerstudy bythe same
authorsdid notshowthatrecallbias wasapotentiallyseriouspro-
blem in earlierstudies(9). Itshouldbepointedout, however, that
these biases, although possibly contributory, would not entire-
ly explain all ofthe increased risk observed, as a reduced but
significant risk remained even after taking the biases into
account.
There is lack ofconsistency in the findings in an attempted
replication ofthese studies by the authors. An earlier study by
Eriksson reported a statistically significant 17-fold risk for ex-
posure to2,4,5-trichlorophenoxyaceticacid (2,4,5-T) andother
phenoxy acids, and a 4-fold risk for non-TCDD-containing
phenoxy compounds (4). In a later study, Eriksson reported a
nonstatistically significant risk of only 1.8 for exposure to
2,4,5-T, anegative riskof0.6fornon-TCDD-containingphenoxy
compounds, and astatistically significantriskof5.3forexposure
to "high grade" chlorophenols not containing TCDD (5).
Similarly, Hardell and Sandstromreportedastatistically signifi-
cant6.6-fold riskforexposure tochlorophenolsinonestudy(6),
and on repeating the study, Hardell and Eriksson obtained a
negative riskofbetween0.4and0.5 forexposureto"highgrade"
chlorophenols (7). These inconsistencies are by no means
trivial. Thus, thepicture fromthese studiesisratherconfusing,
anddifficulttointerpretandthuscalls forcaution, particularly
since nearly all ofthe evidence from case-control studies for
TCDD being a human carcinogen is based on these studies.
Therisksreportedwereassociatedwithunusuallyshortperiods
ofexposureandtissuesamplesfromexposedcasesdidnotshow
elevatedlevelsofTCDD. ThefindingsintheSwedishstudies were
remarkable in that risks of up to 6-fold were reported to be
associated with very shortdurationofexposure. Forexample, in
one ofHardell'sstudies, ofthe 11 casesexposed to2,4,5-T, on-
ly 2 wereexposed for morethan ayear(all 10controls wereex-
posed forlessthan ayear)(6). Hardellalsoanalyzedfatsamples
for TCDD from patients with STS and ML who had sprayed
phenoxycompounds morethan 10yearspreviously(10). Rather
unexpectedly, TCDD levels in these STS and ML cases were
found to be well within normal limits(backgroundlevels inthe
general population areusually not morethan20ppt). The mean
level ofTCDD in adipose tissue ofthese Swedish patients was
found to be only 2.7 ppt, which, even if one assumes that the
samples werecollectedonaverage20yearsafterexposureceased
(theauthors said more than 10years), the meanTCDDlevelsof
these patients were on average probably never much above
background levels atanytime intheirlives, ifatall. Infact, the
absence ofelevated TCDD levels in thesepatients canbe inter-
preted to meanthat, indeed, asobserved intheSwedishstudies,
exposure wasbrief, perhaps tothepointofbeinginsignificantfor
most ofthe cases.
The studies show a lackofcorroborationbycohortstudiesof
users. The risksreportedby Hardelland Erikssoninthese case-
control studies stemmed from exposuremainlyduringtheuseof
phenoxyacidherbicides andchlorophenols. Yet, with oneexcep-
tion (11), these findings have not been confirmedby 15 cohort
studies of professional users (sprayers and applicators), even
those conducted within Sweden(12), evenconsideringonlythe
few studies with sufficient power.
There is apossible lackofcorroboration by the National In-
stitute ofOccupational Safety and Health (NIOSH) study. The
recently published mortality study ofa combined group of 12
plants in the United States producing 2,4,5-T, trichlorophenol
(TCP), pentachlorophenol (PCP), andhexachlorophene by the
NIOSH does not confirm the findings of the Swedish case-
control studies as yet (13). The NIOSH cohort study reported
that, contrarytotheSwedishcase-control studies, workersex-
posedtoTCDDforlessthanayearwithapossiblemeanserum
TCDDlevelof640pptatthetimeexposureceasedshowednoex-
cessofSTSorML, evenallowing fora20-yearlatency (13). This
maybeduetothefactthattheNIOSHstudydoesnotyethavesuf-
ficient power to examine risk ofthese rare cancers in this par-
ticularsubgroup. However, iftheseresultshold later, they con-
tradicttheSwedishfindingsinwhich5-to6-foldriskofbothSTS
and ML wereobserved inpersonsmainly with less than 1 year
of exposure to TCDD, particularly as adipose tissue samples
fromexposedSTSand MLcases intheSwedish studiesdid not
show elevated levels ofTCDD (10).
There is insufficientevidenceofdose-responserelationship.
ForSTS, adose-responseanalysiswaseithernotdone(4,6,7)or
arelationshipnotevident(5) forexposuretophenoxy acids. For
exposuretochlorophenols, noanalysis wasdoneintwo studies
(4,6), and in one, a negative risk was observed (7), while in
another, nostudysubjectwasexposedtochlorophenolscontain-
ing TCDD (5). ForML, nosignificantdose-response relation-
shipcouldbedemonstratedforexposuretophenoxycompounds,
and apositiverelationshipwasobservedwithchlorophenols (2).
Animportantpointthathastobeconsidered inanyevaluation
ofputativeTCDDassociationwithcancerinhumans isthatoc-
cupationalgroupsthathavebeenexposedtoTCDD-containing
phenoxys/chlorophenolshavealsobeenexposedtootherchemi-
cals concomitantly, some ofwhich may cause STS and ML in
man or animals (e.g., arsenicals, ethylene dibromide, aniline,
vinylchloride). Moreover, case-controlstudiesofSTS and ML
fromtheU.S. NationalCancerInstituteandothersources have
givenvaluableinsightintohowsignificantrisksofthesediseases
seem to be associated with several other chemicals to which
TCDD workers were concomitantly exposed (14-16).
NoneoftheSwedishcase-control studiescontrolledforthese
other exposures while investigating phenoxy acid or chloro-
phenol exposure, hence the studies did not attempt to rule out
these concomitant exposures as the possible cause ofthe risk
observed inthestudy subjects. Moreover, information on many
oftheseotherchemicals was notcollected. Itisvirtuallycertain
that even ifthey wereaskedabouttheseexposures, the respon-
dentswouldhavebeenunabletoaccuratelyidentifyandrecallex-
posuretomanyofthem. Therealityofthisproblemwasfacedby
one investigator who rather than settle for uncertainty and
possibly unreliabledata, gaveupthismethodofinquiryandused
occupation as a surrogate instead (17).
Arsenicals, which could also cause STS in humans, were
widely usedtopreservewood inSwedish homes (18), yetnone
oftheSwedishcase-control studiesprovidedinformation onthis
exposure; neither did the rest ofthe Swedish studies report on
creosoteexposure, which wasfoundinoneSwedishstudy tobe
moresignificantlyassociatedwith MLthanphenoxyacids (19).
Concomitantexposureis anintractableprobleminall studies
ofoccupational groups (20). Similarly, the NIOSH study by
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Fingerhutetal. (13) reportedthatmostofthe 12 plants involved
were large U.S. chemical manufacturing sites that produced
thousandsofchemicals, and thatTCDD-exposed workers spent
five times longerworkinginotherareasoftheseplants. Further-
more, halfofthe STS cases that featured so prominently in the
NIOSH studycamefromaplantinwhich ithadpreviouslybeen
reported(21)thata substantial proportionoftheworkershadalso
been exposed to other chemicals such as p-aminobiphenyl, a
knownhumanbladdercarcinogenthatalsocauseshemangiosar-
comas in mice (22). Unfortunately, theone study in which the
issueofconcomitant exposures is leastlikelytobeproblematic
(that ofexposed persons intheSevesoaccident)does notyethave
sufficent-latency or power to show consistent patterns (23).
The Italian Case-Control Study
In the Italian study (8), none of the male STS cases was
definitely exposed to phenoxy herbicides, and only two men
could possibly have had any phenoxy exposure. Thus, no in-
creased risk of STS from phenoxy exposure was observed in
males. Similarly infemales, noexcessriskofSTSduetophenoxy
exposure was observed among deceased subjects. The only
evidence relevanttoTCDD inthis study centers aroundthefact
thatamong living women, fourwereclassifiedasdefinitely oc-
cupationally exposed to phenoxy acids and oneaspossibly ex-
posed, giving a relative risk of2.4, which was not statistically
significant. Onfurther restricting theanalysistowomenlessthan
75 years of age who were exposed between 1950 and 1955, a
statistically significant relative riskof15.5 wasobtained. Itis to
be noted thatforthese womendefiniteexposuremeantonlythat
they worked as rice weeders after 1950, since phenoxy com-
pounds were used as chemical weeders in rice fields.
It should be noted that whereas there were ofiicial records
available thatdocumentedtheuseof2,4-dichlorophenoxyacetic
acid (2,4-D) and 2-methyl-4-chlorophenoxyacetic acid (MCPA)
in the study area in the 1950s, no such data were available for
2,4,5-T, thus it is notknown whether2,4,5-T wasactually used
inthe 1950s. Also, duringtheperiod 1950-1955, manualweeding
was in use, and chemical weeding was only experimental. This
can be interpreted to mean that the experimental useof2,4,5-T
during the 1950s was so insignificant that records were notkept.
Hence, the riskof 15.5 reported is forunvalidated exposure. Fur-
thermore, ofthe total offive STS caseswith definite orpossible
exposure, two were chondrosarcomas of the lower limb and
thorax, not soft-tissue sarcomas (only chondrosarcomas ofthe
eyelids and ear lobes are allowed to be coded as soft-tissue sar-
comas in the International Classification of Diseases), for
another STS, histology was uncertain; one was a Kaposi sar-
coma, and one was a leiomyosarcoma. Thus, in this study, ascer-
tainment ofexposure and case definition were suspect, nottak-
ing into account the sparsity ofthe data and the absence ofrisk
in males and deceased females.
IsTherean Exposure Level below
Which TCDD Does Not CauseCancer?
The issue of the level ofexposure, ifany, that TCDD is car-
cinogenic inhumans is ofimportance topolicy makers, and great
care must betaken that thisjudgment is made on asound basis.
TheNIOSH study is withoutdoubtoneofthe largest studies of
occupational exposuretoTCDD, hence itisofconsiderable im-
portance. Serumcollectedfromasampleofworkerswith atleast
20years latency from twooftheplants showed thatpersons ex-
posed 15-37 years ago for less than 1 year had a mean TCDD
levelof78pptascomparedwithameanof462 pptamongthose
with more than 1 year ofexposure (13,24). When these values
were extrapolated to the dates when individuals were last em-
ployedinTCDD-contaminatedjobs, themeanTCDDlevels were
640pptand3600ppt, respectively. Thus, assuming TCDD ex-
posure intheplants are roughly comparable, the NIOSH study
indicates thatpersonsexposedtoTCDDforlessthan 1 yearshow
as yet no statistically significant elevation ofany cancer, even
with mean serum TCDD levels of640ppt atthetime exposure
ceased. Thisfinding sofarisconsistentwithobservations among
individual cohortstudiesofpersons who sprayedphenoxy her-
bicides professionally. Forexample, todate, no individual cohort
study ofsprayers orapplicators (including those with sufficient
power) hasreportedastatistically significantelevationofSTSor
MLorall cancerscombined (3), exceptone (11) inwhichthere
was gross evidence ofmisclassiScation ofSTS and ML cases.
Civilianoccupational sprayers andapplicators canbeassumed
to have TCDD exposure somewhatsimilartothatofU.S. Ranch
Handsand members oftheU.S. Military Chemical Corps who
sprayedphenoxy herbicidesinVietnam. ThemeanserumTCDD
levels among ranch hands 15 and 20 years after exposure ceas-
ed were 115 ppt (range 16.9-423 ppt) and49.4ppt(range 3.2-313
ppt), respectively (25). From these results, the mean serum
TCDD level forthese groups atthetime exposure ceased canbe
extrapolated to be probably less than 500 ppt, and for the in-
dividual withthe highest exposure the level was less than 1700
ppt (25). As with civilian sprayers, nostatistically significant in-
creased risk of STS or ML or all cancers has been observed
among ranchhands ormembers oftheChemical Corps (26-28).
A mean serum TCDD level ofaround 460ppt insprayers/ap-
plicators as agroup is quite significantcomparedtobackground
levels in the general population ofnot morethan 20pptand ison-
ly low compared to mean levels ofmore than 3600 ppt seen in
production workers and the exposed Seveso population
(24,29,35). It is possible that failure of the NIOSH study to
observe increased riskofany cancer inpersons exposed forless
than 1 yearmay beduetothe factthatthestudydoesnothave suf-
ficient poweras yet. However, even if, forthesakeofargument,
group mean levelsof400-60 pptareconsidered low, clearly, the
NIOSH study does not yet show that this level of exposure is
associated with any statistically significant increased risk of
cancer. On the contrary, whatthe NIOSH study shows andwhat
current knowledge supports is that there is as yet no evidence
fromcohortstudies thatexposureto TCDD atsignificant levels
resulting ingroup mean serum TCDD concentrations ofaround
640ppt, i.e., higherthanthatfound even inprofessional sprayers
and applicators, is causally associated with STS or ML, or any
cancer, except possibly thyroid cancer (see below). If these
results hold after further extension offollow-up ofoccupational
cohorts, theyprovide strong evidencethat ifTCDD is eventually
found tobecarcinogenic inhumans, there may be adosethatmay
vary for different cancer sites below which no cancer occurs.
This is consistent with the recent consensus achieved in the
scientific community about the mechanism ofaction ofTCDD
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at the molecular level (31) and also with the animal data (see
below).
NIOSHandIARCINIEHSRegistryStudies
The NIOSH study was a carefully designed and well-con-
ducted study. However, caution should be exercised in inter-
preting thefindings. Overzealous interpretationofthefindings
mayonlyaddfurtherconfusiontoanalreadycomplex issueand
diminishthevalueofthisimportantstudy. Itisofinteresttocom-
parethe findingsoftheNIOSHstudy withtherecentlypublished
resultsofthelargerandequally importantInternational Register
ofPersonsOccupationally ExposedtoPhenoxyAcidsandCon-
taminants bythe International Agency for Research on Cancer
(IARC) sponsoredbytheU.S. NationalInstituteofEnvironmen-
tal Health Sciences (NIEHS) (32,33). This registry involves
pooling not only cohorts derived from TCDD-containing and
non-TCDD-containing phenoxys/chlorophenols manufactur-
ing/formulating plantsliketheNIOSHregistry, butalsocohorts
derived fromprofessional sprayers/applicators ofphenoxy her-
bicides from 10participating countries, involving atotalof18,910
workers (ofwhich about20% were unexposed).
Two important points mustbe taken into account incompar-
ing the findings ofthesetwo registries forworkers in manufac-
turing plants. a) In the NIOSH study, by definition, every sub-
jectwasexposed toTCDD; intheIARCstudy, exposedworkers
were classified only as having probable exposure to TCDD
because, althoughthey wereknowntohaveworked inphenoxy/
chlorophenol plants inwhichTCDDexposuredidoccur, itwas
not known whether individual workers were actually exposed.
Thus, becauseofthepotential formisclassificationofTCDDex-
posureforsomeproductionworkersintheIARC study, alower
riskofagivencancerputatively associatedwithTCDDexposure
in this study forthese workers than inthe NIOSH study would
not be entirely unexpected. b) Although every subject was
exposed to TCDD in the NIOSH study, everyone was also ex-
posed to the parent phenoxys (2,4,5-T or 2,4-D) or chloro-
phenols. Thus, theNIOSHstudy cannotdifferentiatewhetheran
effect is due to TCDD or due to the parent phenoxys/chloro-
phenols. TheIARC study, ontheotherhand, wasabletoidentify
separately workers who worked in phenoxy/chlorophenol-
producing plants in which no TCDD exposure occurred, and
thus potentially has the capacity to distinguish a TCDD effect
from aphenoxy/chlorophenol effect.
The IARC/NIEHS registry reported a 2-fold risk of STS
among workers exposed to phenoxy acids and chlorophenols,
which, rather surprisingly, was the sameboth in workers with
probable exposure to TCDD as well as in workers exposed to
phenoxys/chlorophenols notcontaining TCDD. The increased
risk was observed only among sprayers/applicators, but not
among production workers who had much higher TCDD ex-
posures. It is pertinent to note that at least one ofthe Swedish
case-control studiesalsoreportedsignificantrisksofSTS inper-
sonsexposedtophenoxyherbicidescontainingTCDD(relative
risk = 17.0) and in persons exposed tophenoxy herbicides not
containingTCDD(relativerisk = 4.2) (4); anotherreported a
relative riskof3.3 forexposuretoallphenoxy acids, whichdid
not change when only TCDD-containing phenoxys were con-
sidered (7). Still yet another study reported a 5-fold increased
riskofSTSforexposure tochlorophenols, whichdonotcontain
TCDD (5). TheNCI studies showednoassociationofSTS with
phenoxysandeithershowedexcessofMLinpersonswith2,4-D
exposure (34) orthatexposure to 2,4,5-T or2,4-Dhad similar
risks of 1.6 and 1.5, respectively (16). These types of results,
together with the fact that the majority of studies have been
negative, donotprovideevidenceimplicatingTCDDspecifically
as the cause ofSTS or ML.
Theimportanceofthe statistically significant increased stan-
dardized mortality ratio (SMR) for all cancers observed in the
NIOSH study should perhaps be tempered with some caution,
for the following reasons: Of23 distinct cancer sites studied,
amongpersonswith20-yearlatency, theSMRforthoseexposed
to TCDD forless than 1 year was elevated and actually higher
than the corresponding SMR among persons with 1 or more
yearsofexposure for six sites. Ontheotherhand, the SMR for
those exposed for 1 or more year was elevated and higher than
thecorresponding SMRamongpersonswithlessthan 1 yearof
exposure foronly eight sites. The remaining sitescould not be
similarly compared, aslessthanonedeathwasexpectedineach
case.
Also, intheNIOSH study, itshouldbenotedthatof 12 plants
studied, only2ofthem reporteddeaths from STS, eventhough
atleast 1 wasofcomparablesizeandlatency as 1 ofthe2 which
recordedSTSdeaths. Furthermore, twoofthe fourdeaths (one
fromeachplant) reported as STS ondeath certificates were, in
fact, found not to be STS on histological verification. It is
noteworthy that in one of the two plants with STS, no excess
deaths from all malignant neoplasms were observed, and in a
subset of chloracne workers from which the two STS deaths
originated, theSMRforallcancerswas, infact, muchlessthan
100(35,36). Thisinconsistency isvexingandunderminesefforts
tocleanlyputboththeexcess risksofSTS andall cancers com-
binedunderthesameumbrellaofbeingduetoTCDDexposure.
It is interesting that in the Seveso study, the SMRs for all
cancersinbothmalesandfemalesfromzoneA(themosthighly
contaminated area) were well below unity also, although the
numbersinvolvedwereverysmall, andlatencytooshort. Indeed,
the risk from STS again seemed to be inversely related to risk
fromall cancers combined in less contaminated zones B and R
(23).
ThefactsthatintheNIOSH study notall personswhoshould
be inthecohort showingthehighest risk ofSTS were included
(139workerswithchloracneandpossiblehighTCDDexposure
representing atleast24% ofthecohortwereexcluded from the
study, andnodeath fromSTSasunderlying causewasreported
amongthem), thatperson-yearscouldnotbecountedforcertain
yearsforpersonsknown nottohavediedfromSTS,andthat45%
of the cohort who were alive were excluded from the dose-
responseanalysis, meansthatthe riskofdeath from STS given
in the study has been overestimated, although by how much is
difficult to tell. This problem is particularly ofrelevance con-
sideringthathalfoftheSTS cases were notSTS. Hence, atthis
time, information on STS from the NIOSH study is only ten-
tative, althougharoughcalculationindicatesthatsubstantial STS
riskwould remain, evenallowing forthe overestimation.
The findings in the IARC/NIEHS study with respect to all
malignantneoplasmscombinedseemtocorroboratethoseofthe
NIOSH study, and the failure ofthe elevated riskobserved for
thiscauseofdeath, tobestatistically significant, mayberelated
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tothe lackofamorerigorousdefinitionofTCDDexposureinthe
IARC study. Interestingly, both the NIOSH and IARC/NIEHS
studies observed a slightly elevated butnot statistically signifi-
cant risk for lung cancer, and in the NIOSH study the risk for
respiratory cancer was statistically significant among workers
with morethan 1 yearofexposure toTCDD. TheIARC/NIEHS
study observed a statistically significant 4-fold risk ofthyroid
cancer based on four deaths, with the highest risk specifically
associated with probable TCDD exposure and also excess of
tumors ofother endocrine organs. Unfortunately, the NIOSH
study did notprovide information onthese sites forcomparison.
Lack of Evidence forMalignant
Lymphomas
Finally, itshould bepointedoutthat results from atotal of28
of 29 individual cohort studies of production workers and
sprayers, andalsoboth theIARC/NIEHS andNIOSH registries,
and6of7 case-control studies thatinvestigated TCDD specifi-
cally (3) now indicate thatit isunlikelythatmalignantlymphoma
is causally associated withTCDD exposure because noneofthe
studies showed a statistically significant risk associated with
possible TCDD exposure. The Danishcancer incidence study is
theonly cancer incidence study ofproduction workers andalso
the only cohort study in which anattempt was made to separate
workers engaged in phenoxy production from those engaged in
the production of other chemicals. Importantly, a statistically
significant excess ofMLobserved inthe factory as awholewas
not among workers in phenoxy acids production, but among
workers engaged in the production ofother substances, mainly
pigments (37). This is consistent and reminiscentofthe obser-
vation that the excess ofML reported in Vietnam veterans was
ultimately found to beconcentrated among veterans who served
in ships, without possible exposure to Agent Orange (38). In-
terestingly, a statistically significant excess oflymphomas due
to TCDD in male animals has been reported only when TCDD
was given athigh toxic doses during infancy resulting inthe oc-
currence ofmainly thymic lymphomas (39).
The editorial mentioned in the Introduction (I) closed by
recommending thatmedical history ofapatient with STS should
include a search for dioxin exposure, and, conversely, the
diagnostic workupofsomeproblems reportedby anexposedper-
son should include asearchforSTS. Inordertosafeguardagainst
future spurious associations that might result ifemphasis is laid
on dioxins only, it is recommended that, routinely forevery case
of STS, as part ofthe medical history, a detailed search for all
known and unknown risk factors should be made, including
detailed inquiry into all possible chemical and occupational ex-
posures. Similarly, persons with well-documented highexposure
to TCDD should be put underclose, long-term surveillance for
any significant medical outcome, such as is being done incohort
studies ofcancer incidence ormortality. TheIARC/NIEHS and
NIOSH registeries are resource centers forthese andothertypes
ofinvestigation.
Comparison of Animal Bioassays and
Epidemiologic Findings
It is necessary to compare the results of long-term carcino-
genicity studies ofTCDD in mice, rats, and hamsters (39-48)
with the findings in humans so far. Because the human data
availableareformales, thiscomparison willberestrictedtothis
sexonly. Tumorsobservedtobestatistically significantly inex-
cess include neoplastic nodule ofthe liver/hepatocellular car-
cinoma (39,40,43), thyroid follicular cell adenoma/carcinoma
(40), adrenal cortical adenoma (40,42), lung adenoma/car-
cinoma (40,43), fibroma of subcutaneous tissue (40), hard
palate/nasal turbinates (42), squamouscarcinomaofthetongue
(42), skin carcinoma (45), and thymic lymphomas (from ex-
posureduring infancy) (39). Tumorsobservedinmaleanimals
receiving the higher doses and not in those in the lowest dose
group, or controls, but not statistically significant, include
neoplastic nodule ofthe liver/hepatocellular carcinoma (44),
cholangiocarcinomas, retroperitoneal histiocytomas, glio-
blastoma, astrocytoma, Leydig cell adenoma/sclerosing
seminoma oftestes, adenocarcinoma of kidney, ear duet car-
cinoma, leukemia, fibroma (43), angioma/angiosarcoma
(39,43), fibrosarcoma(42,43), thyroidfollicularcelladenoma/
carcinoma (42), mammary adenocarcinoma (40), fibroma of
subcutaneous tissue (43), intra-abdominal schwannoma/sar-
coma, leiomyosarcoma (42), skincarcinoma (43,46), and non-
thymic lymphomas and squamous cell carcinoma of stomach
(39).
Itissignificantthatinthefeeding/gavagestudies(39,40,42-44),
apartfromthyroid follicularcelladenoma/carcinoma, noother
tumor was statistically significantly inexcess atadoseof0.001
pg/kg/dayor0.01 pg/kg/week. Animalsreceivingthesedoseshad
meanadiposetissuelevelsof540pptatthetimeofsacrifice (42).
This is remarkably consistent with the human data, in which
none ofthe individual cohort studies ofprofessional sprayers
(whohavemeanserumlevelsofTCDDprobably notexceeding
460-500pptasagroupatthetimeexposureceased)exceptone
(11) showsany significantexcessofanycancer. Itisalsoconsis-
tentwiththeNIOSH findingofasyet(powerconsiderations not-
withstanding) nosignificantexcessofanycancerinworkerswith
less than 1 year of exposure to TCDD with a possible mean
serumTCDDlevelof640pptattimeofterminationofexposure.
The fact thatthe thyroid gland was the organ in which the car-
cinogenic action of TCDD was most readily evident in male
animalsisalsoconsistentwiththefactthatthyroidcanceristhe
onlycancerforwhichanexcesswasobservedtobestatistically
significantintheIARC/NIEHS studyinbothsprayersandpro-
duction workers, and specifically associated with TCDD ex-
posure. This finding needs confirmation and further investiga-
tion, particularly toexcludetheroleofotherchemicalexposures
thatareknowntocausethyroidcancerinanimals. Unfortunately,
theNIOSHstudydidnotprovideinformationonthyroidcancer.
It is of note that liver tumors were not observed to be sig-
nificantly inexcessinmaleanimalsgivenTCDD atlevelsofless
than0.5lsg/kg/weekor0.1 pg/kg/day (meanadiposelevelsofless
than 8100ppt). Thisisconsistentwiththeabsenceofexcess risk
oflivercancerintheNIOSHandIARC/NIEHSregistry studies
and also in all other cohort studies, since even in the NIOSH
study with the highest occupational exposure to TCDD, mean
serum TCDD levels in workers exposed for more than a year
(allowing for a20-year latency) wasonly 3600 ppt (24).
It should be noted that, apart from thyroid tumors, all other
tumorsobserved tobestatisticallysignificantly inexcessinmale
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animals were associated with mean adipose tissue levels of
TCDD much above 540 ppt, which in humans may be en-
countered inproduction workers but notusually inprofessional
sprayers asagroup. Thus, furthercomparisonofthehumandata
withanimaldataforthesesites shouldconcentrateonexamina-
tion ofriskofTCDD exposure athighlevels. Because anexcess
ofrespiratory cancerathigh levels ofexposure was reported in
the NIOSH study, and also other endocrine tumors in addition
tothyroid were in excess intheIARC/NIEHS study, these sites
warrant further investigationastheyarecausallyassociated with
TCDD exposure in animals. It is noteworthy that astatistically
significantexcessofSTShasnotbeenreportedinmaleanimals,
although astatistically significantexcessofsubcutaneous fibro-
sarcoma in female rats and mice has been observed (40,41).
Whether thefactthatthesetumors, whichareuncommon, have
been analyzedby histologic type inthese studies ratherthanbe-
ing groupedtogethercontributes tothefailuretoobserveanex-
cess ofSTS in male animals is not known.
Theoccurrence ofonecaseeachofsixdifferenttumortypes,
but none in the control animals, has been reported in rats fed 5
ppt TCDD indiet (43) [which is roughly estimated to be com-
patible with adipose tissueTCDD levelsofpossiblylessthan200
ppt because adipose tissue TCDD levels of540 ppt in animals
mentionedabove were recordedinratsfed22pptTCDD indiet
(42)]. Thedoseof5pptTCDDindietisthelowestdoseatwhich
any tumor has been recorded inTCDD-exposed animals. Since
no tumor has been reported in animals fed 1 pptTCDD in diet
(43), the bioassay data are also consistent with theproposition
that there may be a level ofexposure below which TCDD does
notcausecancer. Aroughguess isthatthisdoseof1 pptTCDD
in diet in animals approaches background levels ofTCDD ex-
posure in thegeneral human population.
The issueofcancerinhumansasaresultofexposuretoTCDD
has been a complex one. However, careful examination and in-
terpretationofthedatareveal remarkableconsistency bothwithin
published human studies and between human and animal
bioassay studies. Available evidence does not support a causal
role for TCDD in the occurrence ofmalignant lymphomas in
men, and for soft-tissue sarcomas, the weight ofevidence on
balance seems to runagainstacausal rolealso(2,20). However,
further clarification of the picture is required for a definite
evaluation tobemade forSTS, sincea) in spiteofthelarge size
ofthe NIOSHand IARC/NIEHS registries, cohort studies still
do not have sufficient power to assess STS riskadequately and
b) it ispossiblethatperhapsonly persons withapredisposition
such aschloracnepatientsorpersonsexposed atextremelyhigh
dosesofTCDDdevelopthedisease. Thereisevidenceofsignifi-
cant human interindividual variation in enzyme induction by
compoundsbelonging totheTCDD-related family-asmuchas
500-fold difference between individuals in one study (49).
Similarly, experiments in rats show that increasing doses of
TCDDdo notresultinformation ofpreneoplastic lesions (liver
foci) until after the dose which results in saturation ofthe Ah
receptor (binding towhichisnecessary foranybiologiceffectof
TCCD tooccur) isexceeded, i.e., atTCDDdosesofaround 30
ng/kg/day, suggesting that TCDD may cause cancer only at
higherdoses(49). Nestedcase-control studies ofSTS orother
candidate cancers withinthe cohortsassembled inthe NIOSH
and IARC/NIEHS registries may shed light on whether it is
TCDDorconcomitantexposures whichaccountsforany, orall
observed risk of STS or other cancers in these occupational
groups. It is imperative that the role ofconcomitant exposures
andthelevelofTCDDexposurebeseriously considered in fur-
ther reports ofepidemiologic studies.
It is interesting to recall that vinyl chloride (VC) causes
angiosarcoma of the liver in humans at a frequency that is
possibly at least 100times less thanthat for STS (50,51). In ad-
dition, thecarcinogenic potency forvinyl chloridein animals is
estimatedtobe50milliontimeslessthanthatofTCDD(52). Yet,
within 6monthsofthereportofthefirstthreecasesofangiosar-
comaoftheliverinavinylchlorideplant, atotalof13caseswere
identified overa 10-yearperiod in four U.S. plants, anda further
6inEurope, making itpossibleforvinylchloridetobedeclared
ahuman carcinogen within that sameyear (50,53). A clear ex-
cessofangiosarcomaoftheliverwasobserved inaplantinwhich
there wereonly atotal of24deaths. Furthermore, 9 ofthe first
11 occupational studies evaluatedby theIARC showedclearex-
cess ofangiosarcomaoftheliver (54). Within lessthan 4 years
ofthe initial cases, a total of64 cases among VC workers had
been identified worldwide (55). Eventaking into consideration
thatplantworkerswereexposedtovinylchlorideatmuchhigher
concentrations thanthosefound forTCDD (54), this shouldbe
comparedtoonly atotal ofeightSTSdeaths that feature inmor-
tality analyses ofboththeNIOSH andIARC/NIEHS registries
involving mostoftheplants inwhichTCDD exposureoccurs in
theWestern world, covering study periodsofmorethan40years
dating back from the 1940s to the present. In fact, in both
registeries, sincethe 1940s, lessthan20soft-tissue sarcomacases
have been reported so far worldwide among workers exposed
both in manufacturing plants and during spraying.
It is hoped that the above discussion will contribute toward
keepingtheissue inproperperspective. Itisstronglyadvised that
evaluations onwhetherTCDDiscarcinogenic inhumans should
bebasedonampleoratleastconsistentandunambiguousdata.
Therearenow sufficientepidemiologic studies inplacethatmay
provide this framework in the near future. For the moment,
focusing onneitherSTS norMLmakesaparticularly strong case
forTCDDbeingahumancarcinogen. Focus shouldnow alsoex-
tend to serious consideration of other target sites identified
throughoccupationalcohortandanimal studiesaspotential can-
didates for itscarcinogenic action, particularly lung cancer, for
which, inadditiontoallcancerscombined, another recent ma-
jor study of TCDD-exposed production workers reported a
statistically significant increased risk(56). Now thatincreased
risk of all cancers combined is being reported in important
TCDD-exposedcohorts (13,33,56), itshould notbedifficult in
thenearfuturewithincreasedstatisticalpowertoobserveexcess
ofspecific sitestobeconsistently statistically significantalso, if
indeed itisTCDDthatispartly orwholly responsible forthese
excesses.
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